We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIR
401
DELISTED
Near Intelligence, Inc. Common Stock
NIR
$120K ﹤0.01%
11,713
PPHP
402
DELISTED
PHP Ventures Acquisition Corp. Class A Common Stock
PPHP
$117K ﹤0.01%
11,256
CHAA.U
403
DELISTED
Catcha Investment Corp Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
CHAA.U
$115K ﹤0.01%
11,401
AMOD
404
Alpha Modus Holdings
AMOD
$19.5M
$114K ﹤0.01%
282
FSRXU
405
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
$114K ﹤0.01%
11,380
+380
+3% +$3.78K
PWUPU
406
DELISTED
PowerUp Acquisition Corp. Unit
PWUPU
$111K ﹤0.01%
10,792
+2,128
+25% +$21.7K
FRXB.U
407
DELISTED
Forest Road Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
FRXB.U
$108K ﹤0.01%
10,760
STI icon
408
Solidion Technology
STI
$54.5M
$107K ﹤0.01%
209
+1
+0.5% +$505
CLBR.U
409
DELISTED
Colombier Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
CLBR.U
$107K ﹤0.01%
10,896
SBC
410
SBC Medical Group
SBC
$321M
$106K ﹤0.01%
+10,424
New +$105K
RFACU
411
DELISTED
RF Acquisition Corp. Unit
RFACU
$103K ﹤0.01%
10,122
ACABU
412
DELISTED
Atlantic Coastal Acquisition Corp. II Unit
ACABU
$103K ﹤0.01%
10,163
+100
+1% +$1.02K
BGSX
413
DELISTED
Build Acquisition Corp.
BGSX
$103K ﹤0.01%
10,246
-34,887
-77% -$346K
CPARU
414
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
$103K ﹤0.01%
10,246
+4,705
+85% +$47K
AENT icon
415
Alliance Entertainment
AENT
$300M
$102K ﹤0.01%
10,047
-6,051
-38% -$60.8K
INAQU
416
DELISTED
Insight Acquisition Corp. Units
INAQU
$102K ﹤0.01%
+10,100
New +$100K
SHUAU
417
DELISTED
SHUAA Partners Acquisition Corp I Unit
SHUAU
$101K ﹤0.01%
9,872
+6,292
+176% +$63.9K
TETEU
418
DELISTED
Technology & Telecommunication Acquisition Corporation Unit
TETEU
$99K ﹤0.01%
9,501
BPACU
419
DELISTED
Bullpen Parlay Acquisition Company Unit
BPACU
$97K ﹤0.01%
+9,500
New +$96.4K
ATCO
420
PUT
DELISTED
Atlas Corp.
ATCO
$96K ﹤0.01%
+3,026
New +$45.7K
ANZUU
421
DELISTED
Anzu Special Acquisition Corp I Units
ANZUU
$94K ﹤0.01%
9,407
-8,093
-46% -$80.4K
HMA.U
422
DELISTED
Heartland Media Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
HMA.U
$91K ﹤0.01%
+8,901
New +$91.8K
EGGF.U
423
DELISTED
EG Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
EGGF.U
$89K ﹤0.01%
+8,853
New +$87.8K
MTVC.U
424
DELISTED
Motive Capital Corp II Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
MTVC.U
$82K ﹤0.01%
+8,017
New +$81.1K
TOACU
425
DELISTED
Talon 1 Acquisition Corp. Unit
TOACU
$81K ﹤0.01%
+7,873
New +$80.6K

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.